Skin cancer drop in Northeast bucks rising rates elsewhere A decline in melanoma cases and deaths in Northeast states bucks a national trend for the deadliest skin cancer and may reflect benefits of strong prevention program.
Seattle Genetics' cancer drug put on clinical hold after four deaths Seattle Genetics Inc said four people had died in trials testing its experimental cancer drug, prompting the U.S. Food and Drug Administration to impose a clinical hold on several early-stage studies.
Many women get double mastectomy when only one breast has tumors Women with cancer in one breast may opt to have both breasts removed even though a double mastectomy isn't always linked to better survival odds, a recent study suggests.
'Word Clouds' comfort families and doctors of dying patients To humanize the intensive care unit and comfort families of the dying, Canadian doctors have found a way to elicit happier memories at the bedside.
Beijing buyers club? China's cancer patients gamble on gray market When her father's lung cancer worsened, Yin Min, a 51-year-old financial broker from Shanghai, faced a choice: pay nearly $3,000 a month for an approved drug or pay a fraction of the price for a generic drug not approved for use in China.
St. Jude's annual giving campaign lets you shop and share With Americans set to spend more than $900 billion shopping this holiday season, there’s one gift we should all consider adding to our list: The gift of hope for thousands of children suffering from cancer.
Older women with breast cancer still left out of medical trials Older women are still underrepresented in medical trials evaluating treatments for breast cancer, according to a new study.
Florescent light helps surgeons target brain tumors Lily Snowden looks like any other young mother in the park with her son, but the 22-year-old has had two bouts with brain cancer, the first when she was 18 years old and the second— stage 3 glioblastoma— when she was pregnant with now-15-month-old Oliver.
